Edition:
United Kingdom

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

1.45USD
23 Apr 2018
Change (% chg)

$-0.01 (-0.68%)
Prev Close
$1.46
Open
$1.49
Day's High
$1.49
Day's Low
$1.45
Volume
7,350
Avg. Vol
85,038
52-wk High
$5.12
52-wk Low
$1.20

Latest Key Developments (Source: Significant Developments)

Neurometrix, Glaxosmithkline Announce Collaboration To Develop Quell Wearable Pain Relief Technology
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Glaxosmithkline Consumer Healthcare Ltd ::NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY.NEUROMETRIX INC - GSK CONSUMER HEALTHCARE ACQUIRES EXCLUSIVE OWNERSHIP OF QUELL TECHNOLOGY FOR MARKETS OUTSIDE U.S..NEUROMETRIX INC - NEUROMETRIX RETAINS EXCLUSIVE OWNERSHIP OF QUELL TECHNOLOGY IN U.S. MARKET..NEUROMETRIX - CO, GSK CONSUMER HEALTHCARE TO CO-FUND DEVELOPMENT OF QUELL TECHNOLOGY FOR 3 YEARS BEGINNING IN 2018 THROUGH 2020.NEUROMETRIX - GSK CONSUMER HEALTHCARE TO PAY CO $5 MILLION FOR ASSETS RELATING TO QUELL TECHNOLOGY FOR MARKETS OUTSIDE U.S.NEUROMETRIX - GSK CONSUMER HEALTHCARE TO PAY CO UP TO $21.5M FOR QUELL UPON ACHIEVEMENT OF CERTAIN MILESTONES.  Full Article

Neurometrix Reports Preliminary 2017 Financial Highlights
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Neurometrix Inc ::NEUROMETRIX REPORTS PRELIMINARY 2017 FINANCIAL HIGHLIGHTS.NEUROMETRIX INC - PRELIMINARY GAAP REVENUE FOR Q4 OF 2017 IS ESTIMATED AT APPROXIMATELY $4.9 MILLION IN COMPARISON WITH $3.7 MILLION IN Q4 2016.  Full Article

NeuroMetrix files for resale of up to 2.7 mln shares of its stock‍​
Tuesday, 8 Aug 2017 

Aug 9 (Reuters) - NeuroMetrix Inc -:NeuroMetrix files for resale of up to 2.7 million shares of co's common stock issuable upon conversion of shares of series F preferred stock - sec filing‍​.  Full Article

Neurometrix announces DPNCheck distribution agreement with Fukuda Denshi in Japan
Thursday, 3 Aug 2017 

Aug 3 (Reuters) - Neurometrix Inc : :Neurometrix announces DPNCheck distribution agreement with Fukuda Denshi in Japan.  Full Article

NeuroMetrix reports Q2 2017 financial results
Thursday, 20 Jul 2017 

July 20 (Reuters) - Neurometrix Inc :Q2 revenue rose 63 percent to $4.3 million.NeuroMetrix Inc - loss from operations was $3.4 million in Q2 2017 versus $4.2 million in Q2 2016.  Full Article

Neurometrix announces $7.0 mln private placement of preferred stock
Tuesday, 11 Jul 2017 

July 10 (Reuters) - Neurometrix Inc :Neurometrix announces $7.0 million private placement of preferred stock.Neurometrix - proceeds of offering will be used for commercialization of quell in united states.Neurometrix - purchase agreement connection with private placement of 7,000 shares of series f convertible preferred stock at price of $1,000 per share.  Full Article

NeuroMetrix announces one-for-eight reverse stock split
Thursday, 11 May 2017 

May 11 (Reuters) - NeuroMetrix Inc ::NeuroMetrix announces one-for-eight reverse split.Announced a one-for-eight reverse split of its common stock effective as of Thursday, May 11, 2017.Trading of co's common stock on NASDAQ Capital Market will continue, on a split-adjusted basis, with opening of markets on May 12, 2017.  Full Article

NeuroMetrix announces allowance for patents for Quell Wearable Pain Relief Technology features
Monday, 8 May 2017 

May 8 (Reuters) - NeuroMetrix Inc ::Notices of Allowance issued for patents covering key features of Quell Wearable Pain Relief Technology by European Patent Office.Expects the three Quell Wearable Pain Relief Technology patents to formally issue by Q3 of 2017.Notices of Allowance has been issued also by Japan Patent Office, and State Intellectual Property Office of People's Republic of China.  Full Article

NeuroMetrix Q1 loss per share $0.91
Thursday, 20 Apr 2017 

April 20 (Reuters) - NeuroMetrix Inc :NeuroMetrix reports Q1 2017 financial results.Q1 revenue rose 89 percent to $4.3 million.Q1 loss per share $0.91.  Full Article

Neurometrix Q4 loss per share $0.52
Thursday, 26 Jan 2017 

Neurometrix Inc : Neurometrix reports Q4 and full year 2016 financial results . Q4 revenue rose 36 percent to $3.7 million .Q4 loss per share $0.52.  Full Article

BRIEF-NeuroMetrix Q1 Revenue Rose 15 Percent To $4.9 Million

* QTRLY NET INCOME WAS $1.2 MILLION IN COMPARISON WITH A NET LOSS OF $3.2 MILLION IN Q1 2017 Source text for Eikon: Further company coverage: